Analyst Sees Ultragenyx Shares Range Bound Despite Positive Data
April 19, 2017 at 12:14 PM EDT
Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) announced positive data from a late-stage study of burosumab in adults with X-linked ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.